ManRos Therapeutics

ManRos Therapeutics is a development-stage biotech company developing new treatments against cystic fibrosis.

Research on cystic fibrosis

ManRos Therapeutics develops novel drug candidates acting against cystic fibrosis. This severe genetic disease affects the CFTR gene and involves phosphorylation abnormalities.
Science                                Pipeline

A leading researcher and a pharmaceutical industry expert

ManRos Therapeutics is led by a specialist in cellular and molecular biology, Dr. Laurent Meijer, and a pharmaceutical industry expert, Dr. Philippe de Lavenne.